SG Americas Securities’s DexCom DXCM Stock Holding History

SG Americas Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$818K	Sell	68,900 -2,000	-3%	-$139K	﹤0.01%	1893
2025 Q4	$1.06M	Hold	70,900	–	–	﹤0.01%	1960
2025 Q3	$702K	Buy	70,900 +58,500	+472%	+$4.63M	﹤0.01%	1801
2025 Q2	$43K	Sell	12,400 -15,600	-56%	-$1.22M	﹤0.01%	2777
2025 Q1	$182K	Sell	28,000 -17,000	-38%	-$1.39M	﹤0.01%	2597
2024 Q4	$72K	Buy	45,000 +17,000	+61%	+$1.26M	﹤0.01%	2831
2024 Q3	$116K	Buy	+28,000	New	+$2.3M	﹤0.01%	2944
2024 Q2	–	Sell	-25,000	Closed	-$25K	–	2960
2024 Q1	$25K	Hold	25,000	–	–	﹤0.01%	2846
2023 Q4	$108K	Hold	25,000	–	–	﹤0.01%	2706
2023 Q3	$365K	Buy	+25,000	New	+$2.82M	﹤0.01%	1967
2023 Q1	–	Sell	-28,500	Closed	-$15K	–	3326
2022 Q4	$15K	Hold	28,500	–	–	﹤0.01%	2955
2022 Q3	$221K	Buy	28,500 +9,700	+52%	+$822K	﹤0.01%	2236
2022 Q2	$309K	Buy	+18,800	New	+$1.72M	﹤0.01%	2364
2020 Q1	–	Sell	-120,000	Closed	-$159K	–	3494
2019 Q4	$159K	Buy	+120,000	New	+$5.69M	﹤0.01%	2648

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SG Americas Securities's DXCM Position: Q1 2026 in Review

SG Americas Securities increased its DexCom (DXCM) stake by 282% in Q1 2026, buying an estimated $106M and bringing the position to 2,065,277 shares worth $130M. The position accounts for 0.14% of the portfolio, ranked #123.

SG Americas Securities first reported a position in DXCM in Q3 2013 and has held it in 42 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

SG Americas Securities held 2,065,277 shares of DexCom worth $130M as of Q1 2026.
SG Americas Securities bought 1,524,219 DexCom shares in Q1 2026, an estimated $106M.
DexCom made up 0.14% of SG Americas Securities's portfolio in Q1 2026, its #123 holding.
SG Americas Securities first reported a position in DexCom in Q3 2013 and has held it in 42 quarters since.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.